Fast Five Quiz: Gastroesophageal Reflux Disease (GERD)

B.S. Anand, MD


July 29, 2021

Guidelines for deprescribing PPIs suggest that adults with upper GI symptoms who have completed a minimum 4-week course of PPI treatment, resulting in resolution of upper GI symptoms, can decrease the daily dose or stop and change to on-demand use. Deprescribing guidelines do not include patients with Barrett esophagus, severe esophagitis (grade C or D), or documented history of bleeding GI ulcers. Guidelines suggest consideration of PPI use in patients who require both an SSRI and NSAID, if the patient has other risk factors for upper GI ulceration or bleeding.

Read more on medications used to treat GERD.

This Fast Five Quiz was excerpted and adapted from the Medscape Drugs & Diseases article Gastroesophageal Reflux Disease.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.